Tom Taulli

Tom Taulli

InvestorPlace Contributor

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Tax E-Filing: What Option Is Best for You?

By Tom Taulli, InvestorPlace Contributor

Tax e-filing is increasingly popular, but there's an increasingly wide menu of options to choose from. Here's what you should know.

Twitter Inc (TWTR) Stock: No Trump Bailout in Q4

By Tom Taulli, InvestorPlace Contributor

Twitter (TWTR) failed to turn a hot election season into anything meaningful in Q4 earnings, and TWTR stock is feeling the pain.

Why Fitbit Inc (FIT) Needs to Wise Up Before It Can Win Again

By Tom Taulli, InvestorPlace Contributor

Fitbit stock isn't Wall Street's darling anymore, as nothing seems to be working. Then again, FIT faces serious issues with its core business.

Twitter Inc (TWTR) Stock May Get Snapped After Earnings

By Tom Taulli, InvestorPlace Contributor

Twitter stock has been horrible for investors lately, and with the Snap IPO on the horizon, things may get even worse for TWTR.

Should I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor

VRX stock is a disaster. Although new management is making moves to fix this, it'll take a long time for Valeant Pharmaceuticals to come back.

Load More